Literature DB >> 6152720

Positive and negative syndromes in chronic schizophrenic inpatients.

L A Opler, S R Kay, V Rosado, J P Lindenmayer.   

Abstract

This study considered whether chronic schizophrenics with positive and negative syndromes represent distinct subtypes. From a survey of 47 schizophrenic inpatients, 18 showed preponderance of productive or deficit features, and four were mixed. The discrete groups were compared on clinical symptoms, cognitive tests, demographic and historical data, and drug side effects. They were significantly distinguished on most criterion symptoms and affect scales but, otherwise, essentially comparable in psychopathology and extrapyramidal symptoms. The tests revealed similar levels of intellectual impairment and visual-motor deficit, yet the negative patients displayed more primitive cognitive mode and greater psychomotor retardation. They also proved older, less educated, more often born in winter-time, hospitalized later in life, and less heavily medicated. The results supported the validity of the positive-negative dimension for identifying schizophrenic subtypes and suggested etiological implications regarding developmental deficiency.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6152720     DOI: 10.1097/00005053-198406000-00002

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  5 in total

Review 1.  Negative symptoms: psychopathological models.

Authors:  J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 2.  A Developmental History of the Positive and Negative Syndrome Scale (PANSS).

Authors:  Stacy Liechti; Gianna Capodilupo; Douglas J Opler; Mark Opler; Lawrence H Yang
Journal:  Innov Clin Neurosci       Date:  2017-12-01

3.  The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.

Authors:  E Sacchetti; C Magri; A Minelli; P Valsecchi; M Traversa; S Calza; A Vita; M Gennarelli
Journal:  Pharmacogenomics J       Date:  2016-02-09       Impact factor: 3.550

4.  Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients.

Authors:  Erin A Hazlett; Monte S Buchsbaum; M Mehmet Haznedar; Randall Newmark; Kim E Goldstein; Yuliya Zelmanova; Cathryn F Glanton; Yuliya Torosjan; Antonia S New; Jennifer N Lo; Vivian Mitropoulou; Larry J Siever
Journal:  Schizophr Res       Date:  2008-02-13       Impact factor: 4.939

5.  The stability of symptoms and syndromes in chronic schizophrenic patients.

Authors:  M Borde; E J Davis; L N Sharma
Journal:  Indian J Psychiatry       Date:  1992-04       Impact factor: 1.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.